MAGEA11 and gastric adenocarcinoma: Given MAGEA11’s putative oncogenic function in STAD, the association of MAGEA11 with PD-L1, PD-1, and CTLA-4 was investigated in the TCGA-STAD database (Figure 6A) and TIMER databases (Figure 6B).